| Literature DB >> 35486321 |
Bataa El-Kafoury1, Fatma Mohamed1, Nehal Bahgat1, Abeer Abd El Samad2, Mona Shawky1, Enas A Abdel-Hady3.
Abstract
PURPOSE: The deleterious effect of visceral adipose tissue accumulation is well known. However, the recent trend in liposuction is mal-directed toward easily accessible subcutaneous fat for the purpose of body shaping. The aim of the present study is to probe the metabolic effects of subcutaneous abdominal adipose tissue lipectomy in ovariectomized obese rats as well as the role of adipokines in these changes.Entities:
Keywords: Lipectomy; Obesity; Ovariectomy; Subcutaneous adipose tissue; Visceral adipose tissue
Mesh:
Year: 2022 PMID: 35486321 PMCID: PMC9464754 DOI: 10.1007/s42000-022-00371-0
Source DB: PubMed Journal: Hormones (Athens) ISSN: 1109-3099 Impact factor: 3.419
Fig. 1Body weight changes in sham-operated (controls), ovariectomized (OVX), and ovariectomized lipectomized (OVXL) rats. Graphs representing the weekly changes in body weight as median values. *: Significance of differences from initial body weight of the same group was calculated with the Wilcoxon signed-rank test at p < 0.05
The time of lipectomy surgery is indicated by a green circle
Body weight (BW), body mass index (BMI), perirenal fat, and liver weight in the studied groups
| 5-week | 10-week | |||||
|---|---|---|---|---|---|---|
| Control | OVX | OVXL | Control | OVX | OVXL | |
| Final BW (g) | 217.5 (200, 230) | 250 (220, 270)a | 222.5 (190, 235)b | 235 (190, 250) | 270 (250, 305)a* | 260 (220, 350)a† |
| Δ BW (%) | 11.56 (5.00, 18.92) | 22.73 (18.42, 33.33)a | 8.72 (−2.27, 17.50)b | 19.05 (10.00, 32.35) | 42.11 (33.33, 47.78)a* | 34.52 (21.05, 59.09)a† |
| Final BMI (g/cm2) | 0.52 (0.49, 0.52) | 0.57 (0.52, 0.60)a | 0.50 (0.43, 0.55)b | 0.53 (0.51, 0.56) | 0.63 (0.57, 0.64)a* | 0.59 (0.52, 0.67)a† |
| Δ BMI (%) | 1.98 (1.96, 2.08) | 16.67 (14.58, 21.28)a | 0.00 (−10.42, 4.17)b | 7.69 (3.77, 8.33) | 27.34 (21.15, 31.25)a* | 21.15 (12.77, 37.50)a† |
| Perirenal fat (g) | 3.30 (1.70, 5.80) | 4.50 (3.60, 6.80)a | 4.35 (2.30, 6.00) | 1.60 (1.20, 2.10) | 7.65 (5.40, 9.20)a* | 5.80 (3.00, 13.10)a† |
| Perirenal fat/BW (%) | 1.46 (0.74, 2.90) | 1.77 (1.46, 2.56) | 2.04 (1.05, 2.73) | 0.68 (0.53, 0.88) | 2.78 (2.16 , 3.07)a* | 2.35 (1.21, 4.23)a |
| Liver weight (g) | 4.80 (4.10, 5.40) | 6.20 (5.10, 7.30)a | 6.75 (4.30, 7.90)a | 4.70 (3.60, 7.10) | 5.40 (4.50, 6.40)* | 4.90 (3.70 ,7.30)† |
| Liver weight/BW (%) | 2.23 (1.86, 2.45) | 2.67 (2.08, 2.84)a | 2.97 (2.00, 3.63)ab | 2.04 (1.67, 3.02) | 1.88 (1.67, 2.22)* | 1.88 (1.67, 2.09)a† |
Values are presented as median (min, max), n = 10 for controls; n = 13 for OVX and OVXL
Significance of differences between groups was calculated with the Mann-Whitney U test at p < 0.05: a, vs. corresponding controls; b, vs. corresponding OVX rats; *, 5-week OVX vs. 10-week OVX; †, 5-week OVXL vs. 10-week OVXL
OVX, ovariectomized rats; OVXL, ovariectomized lipectomized rats
Biochemical parameters of the studied groups
| 5-week | 10-week | |||||
|---|---|---|---|---|---|---|
| Control | OVX | OVXL | Control | OVX | OVXL | |
| FBG (mg/dl) | 70.00 (62.00, 76.00) | 85.00 (61.00, 96.00)a | 102.00 (80.00, 144.00)ab | 70.00 (63.00, 78.00) | 67.00 (53.00, 75.00)* | 81.00 (61.00, 135.00)ab† |
| TG (mg/dl) | 39.74 (25.12, 56.81) | 48.86 (25.00, 82.13) | 63.20 (32.85, 104.76)a | 33.94 (21.85, 49.58) | 42.02 (33.61, 52.96)a | 39.50 (25.21, 62.18)† |
| TC (mg/dl) | 59.44 (55.10, 85.19) | 78.70 (52.78, 87.96)a | 70.91 (62.04, 92.59)ab | 71.95 (51.06, 92.91) | 76.60 (68.10, 96.32) | 88.65 (73.76, 121.28)ab† |
| HDL-C (mg/dl) | 39.88 (30.41, 48.81) | 43.03 (33.33, 49.72) | 28.66 (20.83, 34.43)ab | 45.71 (23.97, 69.78) | 49.50 (41.39, 64.91)* | 49.50 (40.32, 66.02)† |
| LDL-C (mg/dl) | 13.68 (10.66, 25) | 21.64 (14.13, 34.30)a | 31.35 (21.03, 53.15)ab | 18.05 (13.38, 27.22) | 20.06 (13.76, 28.43) | 31.92 (20.32, 47.67)ab |
| AI | 0.58 (0.39, 0.81) | 0.84 (0.58, 1.00)a | 1.59 (1.22, 1.98)ab | 0.57 (0.33, 0.86) | 0.54 (0.43, 0.78)* | 0.79 (0.57, 1.14)ab† |
| Total proteins (g/dl) | 6.53 (6.34, 7.45) | 6.24 (5.55, 6.91)a | 5.22 (4.88, 5.65)ab | 5.80 (5.44, 7.09) | 5.94 (5.59, 6.21)* | 6.72 (5.86, 7.26)ab† |
| Albumin (g/dl) | 3.91 (3.01, 4.62) | 3.62 (3.01, 4.82) | 2.26 (2.02, 3.33)ab | 3.56 (3.21, 4.18) | 2.99 (2.46, 3.71)a* | 2.36 (2.10, 2.51)ab |
| ALT (IU/l) | 28.92 (24.11, 30.80) | 34.82 (31.25, 44.64)a | 21.43 (16.07, 27.68)ab | 26.78 (21.88, 33.93) | 35.30 (28.57, 42.86)a | 30.00 (22.32, 41.96)† |
| AST (IU/l) | 52.89 (44.23, 78.85) | 75 (63.46, 88.46)a | 55.19 (48.08, 69.23)b | 54.81 (49.62, 63.46) | 51.92 (48.08, 62.50)* | 56.73 (42.31, 72.12) |
| Plasma MDA (nmol/ml) | 32.50 (27.00, 39.00) | 105.00 (64.00, 136.00)a | 173.50 (128.00, 229.00)ab | 42.00 (26.00, 58.00) | 122.50 (102.00, 161.00)a* | 194.00 (166.00, 221.00)ab |
| Blood GSH (mg/dl) | 27.53 (25.14, 33.60) | 26.26 (19.86, 30.06) | 16.74 (10.00, 20.40)ab | 22.40 (19.46, 25.53) | 24.66 (20.53, 27.13) | 23.00 (19.46, 25.20)† |
| Hepatic GSH (mg/g) | 34.21 (29.74, 45.23) | 24.39 (22.08, 27.95)a | 15.16 (10.38, 17.23)ab | 31.71 (25.19, 47.59) | 23.60 (20.67, 28.96)a | 12.75 (10.55, 18.61)ab |
| Leptin (pg/ml) | 50.75 (31.60, 91.39) | 179.66 (111.03, 330.04)a | 89.35 (12.81, 238.51)b | 37.28 (32.95, 59.47) | 142.55 (115.43, 218.77)a | 29.98 (8.15, 135.62)b |
| Adiponectin (ng/ml) | 20.12 (13.18, 27.90) | 17.02 (13.17, 23.47) | 19.54 (15.09, 21.31) | 15.88 (13.69, 17.25) | 15.98 (12.70, 17.40) | 16.34 (11.53, 18.48)† |
Values are presented as median (min, max), n = 10 for controls; n = 13 for OVX and OVXL
Significance of differences between groups was calculated with the Mann-Whitney U test at p < 0.05: a, vs. corresponding controls; b, vs. corresponding OVX rats; *, 5-week OVX vs. 10-week OVX; †, 5-week OVXL vs. 10-week OVXL
OVX, ovariectomized rats; OVXL, ovariectomized lipectomized rats; FBG, fasting blood glucose; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; AI, atherogenic index; ALT, alanine aminotransferase; AST, aspartate aminotransferase; MDA, malondialdehyde; GSH, reduced glutathione
Fig. 2Visceral adipose tissue in sham-operated (controls), ovariectomized (OVX), and ovariectomized lipectomized (OVXL) rats. (a) Fat cell size presented as median (min, max), n = 7/group, significance of differences was calculated with the Mann-Whitney U test at p < 0.05: a, vs. corresponding controls; b, vs. corresponding OVX rats; †, 5-week OVXL vs. 10-week OVXL; (b) Adipocytes distribution ranges; (c) Light photomicrographs of sham-operated controls showing normal appearance of white fat cells with thin rim of cytoplasm surrounding a large vacuole of dissolved lipid and flattened peripherally situated nuclei; (d) 5-week OVX rats showing larger fat cells (thin arrow) with irregular membrane and inflammatory cellular infiltration around blood vessels (curved arrow); (e) 10-week OVX rats showing destruction of membranes between fat cells (thin arrow) with appearance of larger irregular fat cells and inflammatory cellular infiltration around large congested blood vessels (curved arrow); (f) 1-week lipectomized rats showing distorted membranes between most of adjacent fat cells (thin arrow) giving larger irregular fat cells with inflammatory cellular infiltration between fat cells and around blood vessels (curved arrow); (g) 6-week lipectomized rats showing distorted membranes between most of adjacent fat cells (thin arrow) with large irregular fat cells and increasing congested vasculature between fat cells with inflammatory cellular infiltration (curved arrow)
Fig. 3Light photomicrographs of rats’ liver sections. (a) Sham-operated rats showing hepatocytes with central round vesicular nuclei and acidophilic cytoplasm nearby portal tract (P); (b) 5-week ovariectomized rats showing swollen hepatocytes, some with small and others with large vacuoles (dissolved fat droplets) around a portal tract (P) with congested blood sinusoids; (c) 10-week ovariectomized rats showing vacuolated hepatocytes with dissolved fat droplets around a portal tract (P), which shows congested blood vessels; (d) 1-week lipectomized rats showing increased vacuolation of hepatocytes (ballooning of hepatocytes with dissolved fat droplets) and inflammatory cellular infiltration in portal tract (P) with decreased size of blood sinusoids; (e) 6-week lipectomized rats showing increased number of swollen variable sized hepatocytes with dissolved fat droplets and flattened peripherally situated nuclei around a portal tract (P)
Fig. 4Light photomicrographs of rats’ aorta. (a) Young control rats showing endothelial cells (thin arrow) of tunica intima, bundles of smooth muscle cells (S) in tunica media with wavy elastic lamellae (arrow head) in-between and tunica adventitia (A) with loose connective tissue with vasa vasorum; (b) 5-week ovariectomized rats showing vacuolation of some smooth muscle fibers (S) with straightening of most parts of elastic lamellae (arrow head) and appearance of round to oval vacuolated cells with small pyknotic nuclei (thick arrow) known as foam cells in outer part of tunica media with inflammatory cellular infiltration in tunica adventitia (A); (c) 10-week young ovariectomized rats showing stickiness of blood cells to the endothelium of tunica intima (thin arrow) and vacuolation of most smooth muscle fibers (S) in tunica media with separation between elastic lamellae, which show discontinuity in some areas (arrow head) with increased number of foam cells (thick arrow) in middle and outer part of tunica media as well as tunica adventitia (A); (d) 1-week lipectomized rats showing vacuolation of most smooth muscle fibers (S) with the presence of foam cells (thick arrow) in outer part of tunicae media and adventitia (A) with increased inflammatory cellular infiltration; (e) 6-week lipectomized rats showing foam cells in all parts of tunicae media and adventitia (A) with straightening of most parts of elastic lamellae
Fig. 5Scatter plot showing the relationship between weight of removed fat/body weight on the day of lipectomy surgery (i.e., ratio of lipectomized subcutaneous fat to body weight) in the lipectomized rat groups (○: 1-week lipectomized; □: 6-week lipectomized) and (a) liver weight; (b) fasting blood glucose; (c) atherogenic index; (d) fat cell size (i.e., average cell size in each group); (e) high-density lipoprotein-cholesterol (HDL-C); (f) blood reduced glutathione (blood GSH)
Body and biochemical parameters 10 weeks after ovariectomy-induced obesity in young and premenopausal rats
| Young | Premenopausal | ||
|---|---|---|---|
| Δ BW (%) | 42.11 (33.33, 47.78) | 23.33 (14.81, 30.36) | 0.000 |
| Δ BMI (%) | 27.34 (21.15, 31.25) | 23.73 (14.29, 29.51) | 0.027 |
| TG (mg/dl) | 42.02 (33.61, 52.96) | 58.41 (40.95, 84.96) | 0.001 |
| TC (mg/dl) | 76.60 (68.10, 96.32) | 91.04 (80.60, 105.97) | 0.012 |
| HDL-C (mg/dl) | 49.50 (41.39, 64.91) | 28.14 (20.48, 34.14) | 0.000 |
| LDL-C (mg/dl) | 20.06 (13.76, 28.43) | 55.13 (42.53, 66.09) | 0.000 |
| AI | 0.54 (0.43, 0.78) | 2.64 (1.67, 2.76) | 0.000 |
| Total proteins (g/dl) | 5.94 (5.59, 6.21) | 6.72 (6.09,7.76) | 0.000 |
| Albumin (g/dl) | 2.99 (2.46, 3.71) | 3.32 (2.96, 4.08) | 0.042 |
| Plasma MDA (nmol/ml) | 122.50 (102.00, 161.00) | 112.00 (93.00, 129.00) | 0.062 |
| Blood GSH (mg/dl) | 24.66 (20.53, 27.13) | 22.06 (19.06, 24.06) | 0.032 |
| Hepatic GSH (mg/g) | 23.60 (20.67, 28.96) | 7.03 (6.13, 7.85) | 0.000 |
| Fat cell size (μm2) | 7361.39 (6133.73, 8754) | 5366.69 (4099.57, 7931.80) | 0.035 |
Values are presented as median (min, max), n = 13 for young, and n = 11 for premenopausal
Significance of differences was calculated with the Mann-Whitney U test at p < 0.05
BW, body weight; BMI, body mass index; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; AI, atherogenic index; MDA, malondialdehyde; GSH, reduced glutathione
Fig. 6Body responses 6 weeks after subcutaneous adipose tissue lipectomy in young and premenopausal rats. Values are presented as median (min, max), n = 13 for young, and n = 11 for premenopausal. Significance of differences was calculated with the Mann-Whitney U test at p < 0.05. BW: body weight; BMI: body mass index; MDA: malondialdehyde; GSH: reduced glutathione